O36.8232 Fetal anemia and thrombocytopenia, third trimester, fetus 2

Name of the Condition

• Fetal anemia and thrombocytopenia, third trimester, fetus 2
• Technical ICD term: O36.8232

Summary

This condition involves reduced red blood cell count (anemia) and low platelet levels (thrombocytopenia) in the second fetus during the third trimester of a multiple gestation pregnancy. It may indicate underlying issues affecting fetal blood cell production or destruction, requiring careful monitoring and evaluation.

Causes

Fetal anemia can result from maternal-fetal blood type incompatibility, inherited red blood cell disorders, or placental abnormalities. Thrombocytopenia may stem from immune-mediated processes, infections, or genetic conditions affecting platelet production. In multiple gestations, placental sharing or unequal blood flow between fetuses may contribute.

Risk Factors

• Maternal conditions such as autoimmune disorders or infections.
• Family history of blood-related genetic disorders.
• Exposure to substances or medications that impact fetal blood cell development.
• Prior pregnancy complications involving fetal blood abnormalities in multiple gestations.

Symptoms

Fetal symptoms are not directly observable, but prenatal care may reveal abnormal ultrasound findings, such as increased blood flow in fetal vessels or signs of growth restriction in the second fetus.

Diagnosis

Diagnosis typically involves prenatal ultrasound with Doppler studies to assess blood flow, maternal blood tests for antibody screening, and, if indicated, invasive testing like cordocentesis to measure fetal blood counts. Monitoring may focus on the second fetus specifically.

Treatment Options

Treatment depends on severity and may include intrauterine transfusions for anemia, corticosteroids to support platelet production, or close observation. Management may differ between fetuses in multiple gestations.

Prognosis and Follow-Up

Prognosis varies based on underlying causes and response to treatment. Regular prenatal monitoring is essential to track fetal well-being. Postnatal care may involve evaluating both fetuses for persistent blood abnormalities.

Complications

Complications can include fetal growth restriction, preterm labor, or increased risk of bleeding in the affected fetus. In severe cases, anemia or thrombocytopenia may lead to organ damage or fetal demise.

Lifestyle & Prevention

Prenatal care should include avoiding known teratogens, managing maternal health conditions, and adhering to recommended screening protocols. Genetic counseling may be beneficial for families with a history of blood disorders.

When to Seek Professional Help

Seek care if prenatal ultrasounds show abnormal findings, fetal movement decreases, or maternal symptoms (e.g., bleeding) occur. Prompt evaluation is critical for timely intervention.

Tips for Medical Coders

Document the specific fetus (fetus 2) and trimester clearly. Ensure differentiation from other fetal conditions in multiple gestations. Code O36.8232 is specific to the third trimester and the second fetus; verify documentation supports this specificity.